GleamWall
中文EN

MLSS MILESTONE SCIENTIFIC INC.

Orthopedic, Prosthetic & Surgical Appliances & Supplies · NYSE · SEC CIK 855683 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY3.9%
TTM net income YoY46.6%
TTM EPS YoY55.6%
Revenue 3-yr CAGR-1.8%
Net income 3-yr CAGR—

Margins

Gross margin70.9%
Operating margin-40.0%
Net margin-38.3%
FCF margin-16.0%
EBITDA margin-39.2%

Returns

ROE-114.7%
ROA-46.1%
ROIC (approx.)-165.6%
Asset turnover1.20x

Leverage & solvency

Liabilities / assets47.3%
Debt / equity0.00x
Current ratio2.06x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.41x
Accruals ratio-27.1%
Payout ratio—
Capex / revenue0.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$8.97M$8.63M
Cost of revenue$2.57M$2.20M
Gross profit$6.41M$6.43M
R&D expense$449,469$858,767
SG&A expense$11.58M$12.30M
Operating income-$5.70M-$6.76M
Pretax income-$5.72M-$4.71M
Net income-$5.72M-$4.71M
EBITDA-$5.62M-$6.72M
EPS (basic)-0.07-0.06
EPS (diluted)-0.07-0.06
Weighted avg. shares (diluted)82.06M79.79M
Banking
Net interest income—$60,265
Balance sheet
Cash & equivalents$1.11M$3.26M
Short-term investments—$0
Receivables—$475,376
Inventory$3.78M$3.71M
Current assets$7.48M$9.29M
PP&E, net$19,193$12,921
Intangibles$79,063$148,404
Total assets$7.81M$9.80M
Current liabilities$3.94M$3.74M
Total liabilities$4.80M$3.96M
Shareholders' equity$3.01M$5.83M
Shares outstanding80.45M78.01M
Cash flow statement
Operating cash flow-$2.92M-$2.92M
Capital expenditure$15,124$10,124
Free cash flow-$2.93M-$2.93M
Investing cash flow-$15,124$2.97M
Financing cash flow$786,335$233,771
Depreciation & amortization$78,195$37,448
Stock-based compensation$952,716$1.35M

Free plan shows the latest 2 periods; Pro shows all 16 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.